I don't have specific information on the barcode 4007593440004 reported as Kalemtiras. Kaleltiras is an FDA-approved medication used to treat HIV-1 infection, specifically for maintenance therapy. It's a combination of two antiretroviral medications: rilpivirine (400 mg/100 mL) and emtricitabine (200 mg/100 mL).
Regarding the price, it may vary depending on the location, pharmacy, and insurance coverage. On average, Kaleltiras can cost between $1,300 to $2,000 per month for a 28-day cycle.
There are no known warnings or concerns related to this product specifically. However, as with any medication, there are potential side effects, such as:
It's essential to note that Kaleltiras should not be taken without consulting a healthcare professional, as it can interact with other medications and have adverse effects in certain individuals.
If you're looking for more information on Kaleltiras or have specific questions, I recommend consulting the FDA website, the manufacturer's website, or speaking with a healthcare professional.
Was this product information useful?
Do you recommend this product?
Votes: Good (0) | Bad (0)
Votes: Yes (1) | No (0)